SAU:2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation · SAU · Healthcare · SAR · FY for 2025
Figures on this page computed 2026-11-08 13:23 UTC
Last close
n/aSAR
Market data
15.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
10.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
10.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SAR
- computed
Safety is the furthest below its sector's middle: 0.33 against 0.53 on the market's range.
- Growth1.8%55 of 100, above its sector
- Returns on capital11.6%72 of 100, above its sector
- Margins46.6%70 of 100, above its sector
- Price15.5x55 of 100, above its sector
- Safety1.2833 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Sales
132Profit
69.1Shares in issue
99.8Sales is at 132, Profit is at 69, Shares in issue is at 100, against 100 in 2013.
Sales is at 132, Profit is at 69, Shares in issue is at 100, against 100 in 2013.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales, where the first year is 100132
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Profit, where the first year is 10069
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR
Shares in issue, where the first year is 100100
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- SAR